Study Tests New Osteoporosis Drug
A study under way at UAB is testing the effectiveness of a new osteoporosis drug to stimulate bone growth. "Other therapies have been proven effective in preventing bone loss, but this is the first one that may actually stimulate the formation of new bone," says Kenneth Saag, M.D., associate professor of medicine at UAB. The drug, called ALX 1-11, has been shown to stimulate bone growth in smaller studies. "This is the first large-scale study of the drug, and the first time that it has been tested in this region of the world." Osteoporosis is the most common form of bone disease and is the leading cause of hip fractures.
Call Joy Carter, Media Relations, 205-934-1676 or [email protected].
RSS